160 related articles for article (PubMed ID: 8136306)
1. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
Battmann T; Bonfils A; Branche C; Humbert J; Goubet F; Teutsch G; Philibert D
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):55-60. PubMed ID: 8136306
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.
Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
Krausz A; Friedman AJ
J Drugs Dermatol; 2013 Nov; 12(11):1297-300. PubMed ID: 24358489
[No Abstract] [Full Text] [Related]
4. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
Münster U; Nakamura C; Haberland A; Jores K; Mehnert W; Rummel S; Schaller M; Korting HC; Zouboulis ChC; Blume-Peytavi U; Schäfer-Korting M
Pharmazie; 2005 Jan; 60(1):8-12. PubMed ID: 15700772
[TBL] [Abstract][Full Text] [Related]
5. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
Rubina VV; Korchevaia TA; Kravchenko LIa
Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
[No Abstract] [Full Text] [Related]
6. The antiandrogens. When and how they should be used.
Sawaya ME; Hordinsky MK
Dermatol Clin; 1993 Jan; 11(1):65-72. PubMed ID: 8435919
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders.
Battmann T; Branche C; Bouchoux F; Cerede E; Philibert D; Goubet F; Teutsch G; Gaillard-Kelly M
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.
Pan HJ; Wilding G; Uno H; Inui S; Goldsmith L; Messing E; Chang C
Endocrine; 1998 Aug; 9(1):39-43. PubMed ID: 9798729
[TBL] [Abstract][Full Text] [Related]
9. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
Burke BM; Cunliffe WJ
Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
[No Abstract] [Full Text] [Related]
10. [Anti-androgens. Their use in dermatology].
Montero ED; Arevalo A; Michelotti M
Med Cutan Ibero Lat Am; 1981; 9(4):275-84. PubMed ID: 6456390
[TBL] [Abstract][Full Text] [Related]
11. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM
Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993
[TBL] [Abstract][Full Text] [Related]
12. Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: relation of their systemic activity to the formation of a common metabolite.
Cousty-Berlin D; Bergaud B; Bruyant MC; Battmann T; Branche C; Philibert D
J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):47-55. PubMed ID: 7947350
[TBL] [Abstract][Full Text] [Related]
13. [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
Kaiser E
MMW Munch Med Wochenschr; 1980 Jun; 122(26):975-80. PubMed ID: 6158681
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
15. [Indications and limits of anti-androgen therapy].
Zaun H
Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
[TBL] [Abstract][Full Text] [Related]
16. Antiandrogen therapy for skin and hair disease.
Harper JC
Dermatol Clin; 2006 Apr; 24(2):137-43, v. PubMed ID: 16677962
[TBL] [Abstract][Full Text] [Related]
17. [Dermatologic indications for anti-androgenic treatment].
Zaun H; Ludwig E
Z Hautkr; 1978 Nov; 53(21):759-65. PubMed ID: 82309
[TBL] [Abstract][Full Text] [Related]
18. Local inhibition of sebaceous gland growth by topically applied RU 58841.
Matias JR; Gaillard M
Ann N Y Acad Sci; 1995 Jun; 761():56-65. PubMed ID: 7625751
[TBL] [Abstract][Full Text] [Related]
19. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)].
Belaube P; Devaux J; Gamby T; Garcin G; Privat Y
Sem Hop; 1982 Jul; 58(26-27):1650-3. PubMed ID: 6287643
[TBL] [Abstract][Full Text] [Related]
20. The role of androgen and androgen receptor in skin-related disorders.
Lai JJ; Chang P; Lai KP; Chen L; Chang C
Arch Dermatol Res; 2012 Sep; 304(7):499-510. PubMed ID: 22829074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
